Authoritative, Comprehensive, and Free Medical Cannabis Research
Cymbalta, also known as duloxetine, is a drug commonly prescribed for conditions such as anxiety, depression, and chronic pain. As a serotonin and norepinephrine reuptake inhibitor (SNRI), Cymbalta works by increasing the levels of serotonin and norepinephrine in the brain. These chemicals play a crucial role in regulating mood, pain perception, and other important bodily functions. By influencing these neurotransmitters, …
Cannabis has been utilized for pain relief for centuries, with its use for chronic pain becoming increasingly accepted in the medical community. In the United States, many states have recognized chronic pain as a qualifying condition for medical cannabis, reflecting the growing trend of using this natural remedy to alleviate suffering. Beyond the borders of the U.S., individuals worldwide are …
A recent study published in the Journal of the American Medical Association (JAMA) sheds light on the prevalence of delta-8 THC use among adolescents in states where marijuana is illegal. The research reveals that teen use of delta-8 THC is significantly higher in states without marijuana legalization or regulations concerning this psychoactive cannabinoid. The study, conducted by researchers from the …
Cannabis, a plant that has been used for centuries for medicinal and recreational purposes, has gained popularity in recent years due to its potential benefits in treating various medical conditions. However, like any substance, cannabis can also be abused and lead to addiction. In this article, we will explore the topic of cannabis addiction, withdrawal symptoms, and strategies for overcoming …
Doctors are facing a monumental challenge in battling the opioid epidemic, and they are turning to cannabinoids as a potential solution to combat opioid use disorder (OUD). Recent research has focused on creating an open-access framework to help individuals taper off opioids and transition to cannabinoids as an alternative treatment option. A study published last August in the Harm Reduction …
The detection and quantification of delta-9 tetrahydrocannabinol (THC) and its metabolites in blood samples have become increasingly important in forensic toxicology, particularly as the landscape of cannabis decriminalization and legalization continues to evolve. Researchers from the Virginia Department of Forensic Science (DFS) have recently published a comprehensive 107-page report detailing new procedures developed to enhance the selectivity of forensic testing …
The use of counterfeit products has extended to include THC (tetrahydrocannabinol) cartridges, which are commonly used in vaping. The sale of fake THC carts poses a significant health risk due to the unknown and untested ingredients they may contain. It has become increasingly challenging for consumers to distinguish between genuine and fake THC carts, as counterfeit products often imitate popular …
The National Animal Supplement Council (NASC) is at the forefront of promoting a groundbreaking study that has shed light on the safety and efficacy of CBD for long-term use in dogs. The study, recently published in the esteemed journal Frontiers in Veterinary Science, has unveiled promising findings that could revolutionize the treatment of various canine conditions. The research delved into …
Combining Xanax (alprazolam) and cannabis is a practice that has gained popularity in recent years as individuals seek alternative methods for managing stress, anxiety, and pain. While this combination may offer some benefits in terms of stress and anxiety management, it also poses significant risks that should not be overlooked. Before delving into the potential risks associated with combining Xanax …
A groundbreaking study recently published in the journal Current Alzheimer Research has shed light on the potential cognitive benefits of marijuana use. The study, conducted by researchers at SUNY Upstate Medical University in Syracuse, found that individuals who consume cannabis for recreational or medical purposes have lower odds of experiencing subjective cognitive decline (SCD) compared to non-users. The research team …